JCST 2011/S4: 1948-5956-10000S4-1/Special Issue 2011
doi: 10.4172/1948-5956.10000S4
Prognostic utility of BRAF mutation in thyroid cancer
Mingzhao Xing

  

JCST 2011/S4: 1948-5956-10000S4-2/Special Issue 2011
doi: 10.4172/1948-5956.10000S4
New biomarkers of cancer vaccine research
Jeffrey C. Gildersleeve

  

JCST 2011/S4: 1948-5956-10000S4-3/Special Issue 2011
doi: 10.4172/1948-5956.10000S4
Signature molecular biomarkers of prognosis of gastric adenocarcinoma: A study of 114 cases using genome-wide technique and FISH
Dongfeng (Dan) Tan

  

JCST 2011/S4: 1948-5956-10000S4-4/Special Issue 2011
doi: 10.4172/1948-5956.10000S4
Biomarkers for therapy with the EGFR inhibitors
Helmout Modjtahedi

  

JCST 2011/S4: 1948-5956-10000S4-5/Special Issue 2011
doi: 10.4172/1948-5956.10000S4
Tumor specifi c oligomeric forms of protein b23/nucleophosmin
N.M.Vladimirova

  

JCST 2011/S4: 1948-5956-10000S4-6/Special Issue 2011
doi: 10.4172/1948-5956.10000S4
A biomarker and immunomarkers approach for the diagnosis of poorly differentiated neuroendocrine carcinoma
M. H. Bukhari

  

JCST 2011/S4: 1948-5956-10000S4-7/Special Issue 2011
doi: 10.4172/1948-5956.10000S4
Methylation array analysis of tissue DNA in oral squamous cell cancer patients in Taiwan
Yu-Fen Li, Yi-Hsiu Hsiao and Chien-Kuo Tai

  

JCST 2011/S4: 1948-5956-10000S4-8/Special Issue 2011
doi: 10.4172/1948-5956.10000S4
Proximity ligation for visualization of protein-protein interactions in cancer cell signaling and early cancer detection through novel blood based biomarkers
Simon Fredriksson

  

JCST 2011/S4: 1948-5956-10000S4-9/Special Issue 2011
doi: 10.4172/1948-5956.10000S4
Methylation biomarkers - From discovery to clinical use
Tomasz K Wojdacz

  

JCST 2011/S4: 1948-5956-10000S4-10/Special Issue 2011
doi: 10.4172/1948-5956.10000S4
Molecular and biochemical evaluation of anti-proliferative effect of (Cichorium endivia, L.) phenolic extracts
Ali S. Alshehri and Hafez E.E